Search

Your search keyword '"D'Arminio A"' showing total 76 results
Start Over Author "D'Arminio A" Journal jaids journal of acquired immune deficiency syndromes
76 results on '"D'Arminio A"'

1. Estimation of Improvements in Mortality in Spectrum Among Adults With HIV Receiving Antiretroviral Therapy in High-Income Countries

Author

Trickey, Adam, primary, Glaubius, Robert, additional, Pantazis, Nikos, additional, Zangerle, Robert, additional, Wittkop, Linda, additional, Vehreschild, Janne, additional, Grabar, Sophie, additional, Cavassini, Matthias, additional, Teira, Ramon, additional, d’Arminio Monforte, Antonella, additional, Casabona, Jordi, additional, van Sighem, Ard, additional, Jarrin, Inma, additional, Ingle, Suzanne M., additional, Sterne, Jonathan A. C., additional, Imai-Eaton, Jeffrey W., additional, and Johnson, Leigh F., additional

Published
2024
Full Text
View/download PDF

4. Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study

Author

Gori, Andrea, Antinori, Andrea, Vergori, Alessandra, Cossu, Maria Vittoria, Menzaghi, Barbara, Sterrantino, Gaetana, Rusconi, Stefano, Cattelan, Anna Maria, Castelli, Francesco, Gianotti, Nicola, Orofino, Giancarlo, Ripamonti, Diego, Savinelli, Stefano, Manzillo, Elio, Santantonio, Teresa Antonia, Celesia, Benedetto Maurizio, Cauda, Roberto, Maserati, Renato, dʼArminio Monforte, Antonella, Stingone, Christof, Bonora, Stefano, Uglietti, Alessia, Termini, Roberta, Rucci, Francesco, and Mancusi, Daniela

Published
2020
Full Text
View/download PDF

5. Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting

Author

Greenberg, Lauren, Ryom, Lene, Wandeler, Gilles, Grabmeier-Pfistershammer, Katharina, Öllinger, Angela, Neesgaard, Bastian, Stephan, Christoph, Calmy, Alexandra, Rauch, Andri, Castagna, Antonella, Spagnuolo, Vincenzo, Johnson, Margaret, Stingone, Christof, Mussini, Cristina, De Wit, Stéphane, Necsoi, Coca, Campins, Antoni A., Pradier, Christian, Stecher, Melanie, Wasmuth, Jan-Christian, Monforte, Antonella dʼArminio, Law, Matthew, Puhr, Rainer, Chkhartishvilli, Nikoloz, Tsertsvadze, Tengiz, Garges, Harmony, Thorpe, David, Lundgren, Jens D., Peters, Lars, Bansi-Matharu, Loveleen, and Mocroft, Amanda

Published
2020
Full Text
View/download PDF

6. The effect of switching to Maraviroc + Darunavir/ritonavir dual therapy in virologically suppressed patients on the progression of liver fibrosis: findings from a randomized study

Author

Rossetti, B., Gagliardini, R., Sterrantino, G., Colangeli, V., Latini, A., Colafigli, M., Vignale, F., Rusconi, S., Di Biagio, A., Orofino, G., Mezzaroma, I., Vullo, V., Francisci, D., Mastroianni, C., Trezzi, M., Canovari, B., Lamonica, S., Ciccullo, A., Borghetti, A., D’Arminio Monforte, A., Di Giambenedetto, S., and De Luca, A.

Published
2019
Full Text
View/download PDF

7. Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1–Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy

Author

Gras, Luuk, May, Margaret, Ryder, Lars Peter, Trickey, Adam, Helleberg, Marie, Obel, Niels, Thiebaut, Rodolphe, Guest, Jodie, Gill, John, Crane, Heidi, Dias Lima, Viviane, dʼArminio Monforte, Antonella, Sterling, Timothy R., Miro, Jose, Moreno, Santiago, Stephan, Christoph, Smith, Colette, Tate, Janet, Shepherd, Leah, Saag, Mike, Rieger, Armin, Gillor, Daniel, Cavassini, Matthias, Montero, Marta, Ingle, Suzanne M., Reiss, Peter, Costagliola, Dominique, Wit, Ferdinand W.N.M., Sterne, Jonathan, de Wolf, Frank, and Geskus, Ronald

Published
2019
Full Text
View/download PDF

8. Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort

Author

Pelchen-Matthews, A., Borges, A. H., Reekie, J., Rasmussen, L. D., Wiese, L., Weber, J., Pradier, C., Degen, O., Paredes, R., Tau, L., Flamholc, L., Gottfredsson, M., Kowalska, J. D., Jablonowska, E., Mozer-Lisewska, I., Radoi, R., Vasylyev, M., Kuznetsova, A., Begovac, J., Svedhem, V., Clark, A., Cozzi-Lepri, A., Harxhi, A., Losso, M., Kundro, M., Schmied, B., Zangerle, R., Karpov, I., Vassilenko, A., Mitsura, V. M., Paduto, D., Clumeck, N., De Wit, S., Delforge, M., Florence, E., Vandekerckhove, L., Hadziosmanovic, V., Machala, L., Jilich, D., Sedlacek, D., Kronborg, G., Benfield, T., Gerstoft, J., Katzenstein, T., Pedersen, C., Johansen, I. S., Ostergaard, L., Moller, N. F., Nielsen, L. N., Zilmer, K., Smidt, J., Aho, I., Viard, J. -P., Girard, P. -M., Fontas, E., Duvivier, C., Rockstroh, J., Behrens, G., Stellbrink, H. J., Stephan, C., Goethe, J. W., Bogner, J., Fatkenheuer, G., Chkhartishvili, N., Sambatakou, H., Adamis, G., Paissios, N., Szlavik, J., Kelly, C., Turner, D., Burke, M., Shahar, E., Hassoun, G., Elinav, H., Haouzi, M., Elbirt, D., D'Arminio Monforte, A., Esposito, R., Mazeu, I., Mussini, C., Mazzotta, F., Gabbuti, A., Lazzarin, A., Castagna, A., Gianotti, N., Galli, M., Ridolfo, A., Uzdaviniene, V., Matulionyte, R., Staub, T., Hemmer, R., Dragas, S., Stevanovic, M., Reiss, P., Trajanovska, J., Reikvam, D. H., Maeland, A., Bruun, J., Knysz, B., Gasiorowski, J., Inglot, M., Bakowska, E., Flisiak, R., Grzeszczuk, A., Parczewski, M., Maciejewska, K., Aksak-Was, B., Beniowski, M., Mularska, E., Kamerys, J., Wojcik, K., Rozplochowski, B., Zagalo, A., Mansinho, K., Maltez, F., Oprea, C., Yakovlev, A., Trofimora, T., Khromova, I., Kuzovatova, E., Borodulina, E., Vdoushkina, E., Ranin, J., Tomazic, J., Miro, J. M., Laguno, M., Martinez, E., Garcia, F., Blanco, J. L., Martinez-Rebollar, M., Mallolas, J., Callau, P., Rojas, J., Inciarta, A., Moreno, S., del Campo, S., Clotet, B., Jou, A., Puig, J., Llibre, J. M., Santos, J. R., Domingo, P., Gutierrez, M., Mateo, G., Sambeat, M. A., Laporte, J. M., Falconer, K., Thalme, A., Sonnerborg, A., Treutiger, C. J., Scherrer, A., Weber, R., Cavassini, M., Calmy, A., Furrer, H., Battegay, M., Schmid, P., Mikhalik, J., Sluzhynska, M., Milinkovic, A., Johnson, A. M., Simons, E., Edwards, S., Phillips, A., Johnson, M. A., Mocroft, A., Orkin, C., Winston, A., Leen, C., Wandeler, G., Lundgren, J., Guaraldi, G., Kirk, O., Peters, L., Bojesen, A., Raben, D., Hansen, E. V., Kristensen, D., Larsen, J. F., Fischer, A. H., Amele, S., and Roen, A.

Subjects
Adult, Male, antiretroviral treatment, medicine.medical_specialty, Anti-HIV Agents, Human immunodeficiency virus (HIV), non-AIDS-defining clinical conditions, Comorbidity, Rate ratio, medicine.disease_cause, symbols.namesake, heavily treatment experienced, Acquired immunodeficiency syndrome (AIDS), Antiretroviral Therapy, Highly Active, Internal medicine, medicine, Humans, Pharmacology (medical), Prospective Studies, Poisson regression, Prospective cohort study, Acquired Immunodeficiency Syndrome, business.industry, Confounding, HIV resistance, acquired immunodeficiency syndrome, Middle Aged, Viral Load, prevalence, outcomes, heavily, treatment-experienced, individuals, HIV, medicine.disease, Europe, AIDS, Treatment Outcome, Infectious Diseases, Cohort, symbols, Female, business, Viral load
Abstract

Background: Although antiretroviral treatments have improved survival of persons living with HIV, their long-term use may limit available drug options. We estimated the prevalence of heavily treatment-experienced (HTE) status and the potential clinical consequences of becoming HTE. Setting: EuroSIDA, a European multicenter prospective cohort study. Methods: A composite definition for HTE was developed, based on estimates of antiretroviral resistance and prior exposure to specific antiretroviral regimens. Risks of progressing to clinical outcomes were assessed by Poisson regression, comparing every HTE individual with 3 randomly selected controls who never became HTE. Results: Of 15,570 individuals under follow-up in 2010-2016, 1617 (10.4%, 95% CI: 9.9% to 10.9%) were classified as HTE. 1093 individuals became HTE during prospective follow-up (HTE incidence rate 1.76, CI: 1.66 to 1.87 per 100 person-years of follow-up). The number of HTE individuals was highest in West/Central Europe (636/4019 persons, 15.7%) and lowest in East Europe (26/2279 persons, 1.1%). Although most HTE individuals maintained controlled viral loads (

Published
2021
Full Text
View/download PDF

11. Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir–Ritonavir Plus Either Raltegravir or Tenofovir–Emtricitabine: A Substudy of the NEAT001/ANRS143 Trial

Author

Winston, Alan, Stöhr, Wolfgang, Antinori, Andrea, Amieva, Helene, Perré, Philippe, De Wit, Stephane, Reynes, Jacques, Gompels, Mark, dʼArminio Monforte, Antonella, Gatell, Jose-Maria, Grarup, Jesper, Pozniak, Anton, Babiker, Abdel, Raffi, François, and Richert, Laura

Published
2017
Full Text
View/download PDF

12. Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The 'STORE' Study

Author

Alessandra Vergori, Elio Manzillo, Roberta Termini, Andrea Antinori, Diego Ripamonti, Antonella dʼArminio Monforte, Christof Stingone, Nicola Gianotti, Stefano Savinelli, Benedetto Maurizio Celesia, Francesco Castelli, Renato Maserati, Teresa Santantonio, Giancarlo Orofino, Barbara Menzaghi, Francesco Rucci, Maria Vittoria Cossu, Roberto Cauda, Gaetana Sterrantino, Anna Maria Cattelan, Alessia Uglietti, Andrea Gori, Stefano Rusconi, Daniela Mancusi, and Stefano Bonora

Subjects
Adult, Male, medicine.medical_specialty, Settore M-PSI/02 - PSICOBIOLOGIA E PSICOLOGIA FISIOLOGICA, Anti-HIV Agents, effectiveness, HIV Infections, 030312 virology, darunavir, cobicistat, ritonavir, HIV, STORE, virologically suppressed, Gastroenterology, 03 medical and health sciences, Internal medicine, HIV Seropositivity, medicine, Humans, darunavir/ritonavir, Pharmacology (medical), Prospective Studies, Adverse effect, Prospective cohort study, Darunavir, therapy, 0303 health sciences, Ritonavir, business.industry, Cobicistat, darunavir/cobicistat, HIV Protease Inhibitors, Middle Aged, Viral Load, Clinical Science, Regimen, Infectious Diseases, Tolerability, haart, HIV-1, RNA, Viral, Female, business, Viral load, medicine.drug
Abstract

Objective: This study investigates the effectiveness and tolerability of switching to a darunavir/cobicistat (DRV/c)-based antiretroviral regimen from a ritonavir-boosted protease inhibitor (PI/r)-based regimen in virologically suppressed HIV-positive patients. DRV trough values were also investigated. Setting: Prospective, multicenter, single-country, noninterventional cohort study. Methods: This study included patients on a PI/r-based ART for at least 12 months having plasma HIV-1 RNA

Published
2020
Full Text
View/download PDF

13. Late Diagnosis of HIV Infection: Epidemiological Features, Consequences and Strategies to Encourage Earlier Testing

Author

Antonella d'Arminio Monforte, Enrico Girardi, and Caroline A. Sabin

Subjects
Male, medicine.medical_specialty, Time Factors, Anti-HIV Agents, MEDLINE, HIV Infections, Acquired immunodeficiency syndrome (AIDS), Pregnancy, Antiretroviral Therapy, Highly Active, Epidemiology, Disease Transmission, Infectious, Prevalence, medicine, Humans, Pharmacology (medical), Sida, biology, business.industry, Transmission (medicine), Public health, HIV, biology.organism_classification, Partner notification, medicine.disease, Risk perception, Infectious Diseases, Family medicine, Immunology, Female, business
Abstract

A substantial proportion of HIV-infected individuals do not present for HIV testing until late in infection; these individuals are often ill, have a high mortality risk, and are less likely to respond to treatment when initiated. Furthermore, late presentation means that opportunities to reduce onward transmission, either by reducing high-risk behaviours or by reducing an individual's infectivity, are missed. The proportion of HIV-infected individuals who present late has remained relatively stable over the past decade, despite several attempts to encourage earlier diagnosis. Late presenters tend to be those at lower perceived risk of infection, those who are not routinely offered HIV testing, and are often from marginalized groups. Strategies that encourage earlier testing, including routine HIV testing in healthcare settings where high-risk individuals attend frequently, the availability of HIV testing services in non-medical settings, and partner notification schemes or peer-led projects to encourage high-risk individuals to attend for testing, may all increase the proportion of HIV-infected individuals who are aware of their HIV status, thus helping to control the spread of the epidemic. This review summarizes recent evidence on the epidemiology of late presentation and its impact on clinical progression, and describes several key strategies that may encourage earlier diagnosis.

Published
2007
Full Text
View/download PDF

14. Regional Changes Over Time in Initial Virologic Response Rates to Combination Antiretroviral Therapy Across Europe

Author

Wendy P. Bannister, Helene Mens, José M. Gatell, Amanda Mocroft, Jens D Lundgren, Brygida Knysz, Antonella d'Arminio Monforte, Andrew N. Phillips, Ole Kirk, and Jean-Paul Viard

Subjects
Male, Cart, Time Factors, Anti-HIV Agents, HIV Infections, Zidovudine, Antiretroviral Therapy, Highly Active, Drug Resistance, Viral, medicine, Antiretroviral naive, Humans, Pharmacology (medical), business.industry, virus diseases, Viral Load, Antiretroviral therapy, Europe, Infectious Diseases, Virologic response, Immunology, HIV-1, Female, business, Viral load, Regional differences, medicine.drug, Calendar time, Demography
Abstract

Background: Changes in virologic response to initial combination antiretroviral therapy (cART) over calendar time may indicate improvements in cART or emergence of primary resistance. Regional variations may identify differences in available antiretroviral drugs or patient management.Methods: Virologic response (viral load < 500 copies/mL) 6 to 12 months after starting cART was analyzed in antiretroviral-naive EuroSIDA patients. Analyses were stratified by region (south, central west, north, east) or time started cART (early, 1996-1997; mid, 1998-1999; late, 2000-2004).Results: Virologic suppression was achieved by 60% of 2102 patients: 57% south (n = 560), 61% central west (n = 466), 63% north (n = 606), 58% east (n = 470) (P = 0.091). An increase was observed over time: 2% early cART, 56% mid cART, 69% late cART (P < 0.001). Overall, there were significant effects of region (P = 0.026) and time (P < 0.001) on virologic response after adjustment for confounders. Stratified by period, regional differences were less evident (early cART, P = 0.967; mid cART, P = 0.291; late cART, P = 0.163). Stratified by region, temporal changes were observed (south, P 0.061; central west, P < 0.001; north: P = 0.070; east, P = 0.001).Conclusions: There was some evidence of regional differences in initial virologic response to cART. Improvements over time were observed, suggesting that so far,the effect of primary resistance has not been of sufficient magnitude to prevent increasing suppression rates.

Published
2006
Full Text
View/download PDF

15. Is Moderate HIV Viremia Associated With a Higher Risk of Clinical Progression in HIV-Infected People Treated With Highly Active Antiretroviral Therapy

Author

A. Poggio, Alessandro Cozzi Lepri, D. Santoro, Paola Cicconi, Giuliano Rizzardini, Vincenzo Colangeli, Maria Montroni, Massimo Arlotti, Antonella d'Arminio Monforte, Rita Murri, Giulia Tositti, and Maria Luisa Soranzo

Subjects
Male, medicine.medical_specialty, HIV Infections, Viremia, Cohort Studies, Acquired immunodeficiency syndrome (AIDS), Risk Factors, Antiretroviral Therapy, Highly Active, Internal medicine, medicine, Humans, Pharmacology (medical), Poisson Distribution, Sida, Acquired Immunodeficiency Syndrome, biology, business.industry, medicine.disease, biology.organism_classification, Confidence interval, Infectious Diseases, Italy, Relative risk, Immunology, Cohort, Disease Progression, Regression Analysis, Female, business, Viral load, Cohort study
Abstract

To assess the risk of clinical progression (CP) according to the duration of time spent without complete viral load (VL) suppression compared with that associated with periods of stably suppressed viremia in HIV-infected people who started highly active antiretroviral therapy (HAART) when previously naïve to antiretrovirals.A cohort study of patients having started HAART after enrollment in the Italian Cohort of Antiretroviral-Naive Patients (ICoNA) and being followed for at least 6 months.Person-years spent in different categories according to the VL level and the change in VL from the most recent value before the initiation of HAART were calculated. A multivariable Poisson regression model, including potential confounders, was constructed.A total of 3023 patients were studied. The overall rate of CP was 13.4 per 1000 person-years. Evidence for a higher risk of CP was observed for people with a current VL10,000 copies/mL. For each year longer spent on HAART with a VL100,000 copies/mL, a 5-fold increased risk was observed (relative risk [RR] = 5.34, 95% confidence interval [CI]: 2.83 to 1.08; P = 0.0001). An increased risk of CP in patients with current suppression1.5 log10 copies/mL (RR = 2.34, 95% CI: 1.16 to 4.74; P = 0.02) and in those with no suppression or a VL higher than their set point (RR = 2.39, 95% CI: 1.17 to 4.89; P = 0.02) was observed compared with those with suppression of3 log10 copies/mL, although it was not significant. Longer duration on HAART with a VL suppressed below set point seemed to confer protection against CP.Virologic failure to antiretroviral drugs is common. The risk of CP may remain low despite a low but detectable level of HIV viremia.

Published
2006
Full Text
View/download PDF

16. Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral Therapy

Author

Andrea Antinori, Izzo Cm, Patrizio De Longis, Alfredo Scalzini, Adriana Ammassari, Antonella d'Arminio Monforte, Maria Paola Trotta, Rita Murri, F. Starace, and Albert W. Wu

Subjects
medicine.medical_specialty, Depression, business.industry, Cross-sectional study, HIV Infections, medicine.disease, Mental health, Comorbidity, Substance abuse, Cross-Sectional Studies, Infectious Diseases, Acquired immunodeficiency syndrome (AIDS), Risk Factors, Antiretroviral Therapy, Highly Active, Intervention (counseling), Humans, Patient Compliance, Medicine, Pharmacology (medical), Risk factor, business, Psychiatry, Depression (differential diagnoses)
Abstract

Affective disorders have been reported as the most common mental health problem in persons with HIV infection. Depression has a significant impact on the quality of life of persons living with HIV and AIDS and is associated with HIV disease progression and mortality, even after controlling for sociodemographic and clinical characteristics and substance abuse. Depression has been also reported as one of the main causes of poor adherence with antiretroviral regimens. However, no published investigation has specifically focused on the relationship between depression and adherence to antiretroviral therapy. Nonetheless, information on the association between depressive symptoms and adherence may be gathered from investigations carried out to explore determinants of adherence with antiretroviral therapy. Findings from available studies show a substantial and consistent relationship between adherence to antiretroviral regimens and depression. Early recognition and proper management of depressive comorbidity could be an effective intervention strategy to improve adherence and may make a difference in the quality of life, social functioning, and disease course of people with HIV.

Published
2002
Full Text
View/download PDF

17. Serum α-Fetoprotein Levels Predict Early Virologic Response in HIV-Positive Subjects Treated for Chronic Hepatitis C

Author

Maddalena Casana, Giulia Marchetti, Antonella d'Arminio Monforte, Camilla Tincati, Roberto Ranieri, and Marco Bongiovanni

Subjects
medicine.medical_specialty, Infectious Diseases, Chronic hepatitis, business.industry, Internal medicine, Virologic response, Human immunodeficiency virus (HIV), medicine, Pharmacology (medical), Serum alpha-fetoprotein, medicine.disease_cause, business, Gastroenterology
Published
2008
Full Text
View/download PDF

18. Discontinuation of Initial Antiretroviral Therapy in Clinical Practice

Author

Di Biagio, Antonio, primary, Cozzi-Lepri, Alessandro, additional, Prinapori, Roberta, additional, Angarano, Gioacchino, additional, Gori, Andrea, additional, Quirino, Tiziana, additional, De Luca, Andrea, additional, Costantini, Andrea, additional, Mussini, Cristina, additional, Rizzardini, Giuliano, additional, Castagna, Antonella, additional, Antinori, Andrea, additional, and d'Arminio Monforte, Antonella, additional

Published
2016
Full Text
View/download PDF

19. Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals

Author

May, Margaret T., primary, Justice, Amy C., additional, Birnie, Kate, additional, Ingle, Suzanne M., additional, Smit, Colette, additional, Smith, Colette, additional, Neau, Didier, additional, Guiguet, Marguerite, additional, Schwarze-Zander, Carolynne, additional, Moreno, Santiago, additional, Guest, Jodie L., additional, Monforte, Antonella d'Arminio, additional, Tural, Cristina, additional, Gill, Michael J., additional, Bregenzer, Andrea, additional, Kirk, Ole, additional, Saag, Michael, additional, Sterling, Timothy R., additional, Crane, Heidi M., additional, and Sterne, Jonathan A. C., additional

Published
2015
Full Text
View/download PDF

20. Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy

Author

Bruyand, Mathias, primary, Ryom, Lene, additional, Shepherd, Leah, additional, Fatkenheuer, Gerd, additional, Grulich, Andrew, additional, Reiss, Peter, additional, de Wit, Stéphane, additional, d´Arminio Monforte, Antonella, additional, Furrer, Hansjakob, additional, Pradier, Christian, additional, Lundgren, Jens, additional, and Sabin, Caroline, additional

Published
2015
Full Text
View/download PDF

21. Pregnancy Outcomes Among ART-Naive and ART-Experienced HIV-Positive Women

Author

d'Arminio Monforte, Antonella, primary, Galli, Laura, additional, Lo Caputo, Sergio, additional, Lichtner, Miriam, additional, Pinnetti, Carmela, additional, Bobbio, Nicoletta, additional, Francisci, Daniela, additional, Costantini, Andrea, additional, Cingolani, Antonella, additional, Castelli, Francesco, additional, Girardi, Enrico, additional, and Castagna, Antonella, additional

Published
2014
Full Text
View/download PDF

22. Life Expectancy in the Immune Recovery Era

Author

Guaraldi, Giovanni, primary, Cossarizza, Andrea, additional, Franceschi, Claudio, additional, Roverato, Alberto, additional, Vaccher, Emanuela, additional, Tambussi, Giuseppe, additional, Garlassi, Elisa, additional, Menozzi, Marianna, additional, Mussini, Cristina, additional, and D'Arminio Monforte, Antonella, additional

Published
2014
Full Text
View/download PDF

23. Detrimental Effect of Atazanavir Plasma Concentrations on Total Serum Bilirubin Levels in the Presence of UGT1A1 Polymorphisms

Author

Antonella d'Arminio Manforte, Paola Cicconi, Olivia Turri, F. Pateri, Alessandra Barassi, Maria Luisa Biondi, Maddalena Casana, Giulia Marchetti, Teresa Bini, and Gianlodovico Melzi d'Eril

Subjects
Adult, Male, medicine.medical_specialty, Polymorphism, Genetic, Anti-HIV Agents, Pyridines, business.industry, Atazanavir Sulfate, Bilirubin, Middle Aged, Total serum bilirubin, Atazanavir, Plasma, Infectious Diseases, Endocrinology, Internal medicine, Plasma concentration, medicine, Humans, Female, Pharmacology (medical), Glucuronosyltransferase, business, Oligopeptides, medicine.drug
Published
2011
Full Text
View/download PDF

24. Insulin Resistance Affects Early Virologic Response in HIV-Infected Subjects Treated for Hepatitis C Infection

Author

Teresa Bini, Maddalena Casana, Roberto Ranieri, Camilla Tincati, Marco Bongiovanni, Paola Cicconi, Federica Tordato, and Antonella d'Arminio Monforte

Subjects
Adult, Male, business.industry, HIV Infections, Hepacivirus, Hepatitis C, Middle Aged, medicine.disease, Antiviral Agents, Virology, Infectious Diseases, Insulin resistance, Hiv infected, Virologic response, Humans, Medicine, Female, Pharmacology (medical), Viremia, Insulin Resistance, business
Published
2008
Full Text
View/download PDF

25. CD8 T-Cell Activation Is Associated With Lipodystrophy and Visceral Fat Accumulation in Antiretroviral Therapy–Treated Virologically Suppressed HIV-Infected Patients

Author

Guaraldi, Giovanni, primary, Luzi, Kety, additional, Bellistrì, Giusi Maria, additional, Zona, Stefano, additional, Domingues da Silva, Ana Rita, additional, Bai, Francesca, additional, Garlassi, Elisa, additional, Marchetti, Giulia, additional, Capeau, Jacqueline, additional, and d’Arminio Monforte, Antonella, additional

Published
2013
Full Text
View/download PDF

26. Association Between ALT Level and the Rate of Cardio/Cerebrovascular Events in HIV-Positive Individuals

Author

Sabin, Caroline A., primary, Ryom, Lene, additional, Kovari, Helen, additional, Kirk, Ole, additional, de Wit, Stephane, additional, Law, Matthew, additional, Reiss, Peter, additional, Dabis, Francois, additional, Pradier, Christian, additional, El-Sadr, Wafaa, additional, Monforte, Antonella d'Arminio, additional, Kamara, David, additional, Phillips, Andrew N., additional, and Lundgren, Jens D., additional

Published
2013
Full Text
View/download PDF

28. Osteoporosis in HIV-Infected Subjects: A Combined Effect of Highly Active Antiretroviral Therapy and HIV Itself?

Author

Valentina Emanuela Ligabo, Teresa Bini, Marco Bongiovanni, Sara Melzi, Paola Cicconi, Alfonso Fausto, Antonella d'Arminio Monforte, Francesco Sardanelli, Laura Menicagli, and Giampaolo Cornalba

Subjects
Adult, Male, medicine.medical_specialty, Anti-HIV Agents, business.industry, Osteoporosis, Human immunodeficiency virus (HIV), HIV Infections, Middle Aged, medicine.disease_cause, medicine.disease, Antiretroviral therapy, Infectious Diseases, Antiretroviral Therapy, Highly Active, Internal medicine, Hiv infected, medicine, Humans, Female, Pharmacology (medical), business
Published
2005
Full Text
View/download PDF

29. Partnership of HIV-Infected Women and Health Status

Author

Aloisi, M.S., Murri, R., D’Arminio Monforte, A., Bertelli, D., Colangeli, V., Leoncini, F., Ippolito, G., Girardi, E., and Study Group, T.I.C.O.N.A.

Subjects
Adult, Settore MED/17 - Malattie Infettive, business.industry, Health Status, HIV Infections, Sexual Partners, Infectious Diseases, Italy, Hiv infected, General partnership, Environmental health, Linear Models, Humans, Medicine, Female, Pharmacology (medical), Substance Abuse, Intravenous, business
Published
2005
Full Text
View/download PDF

30. Prevalence of Prolonged Amenorrhea in HIV-Infected Women

Author

Cicconi, Paola, primary, Ammassari, Adriana, additional, Ladisa, Nicoletta, additional, Sora, Fiorella Di, additional, Bini, Teresa, additional, Pierro, Paola, additional, D'Ettorre, Gabriella, additional, Cattelan, Anna M., additional, Vichi, Francesca, additional, and Monforte, Antonella d'Arminio, additional

Published
2012
Full Text
View/download PDF

31. Exposure to Abacavir and Biomarkers of Cardiovascular Disease in HIV-1–Infected Patients on Suppressive Antiretroviral Therapy

Author

De Luca, Andrea, primary, de Gaetano Donati, Katleen, additional, Cozzi-Lepri, Alessandro, additional, Colafigli, Manuela, additional, De Curtis, Amalia, additional, Capobianchi, Maria Rosaria, additional, Antinori, Andrea, additional, Giacometti, Andrea, additional, Magnani, Giacomo, additional, Vullo, Vincenzo, additional, Cauda, Roberto, additional, Iacoviello, Licia, additional, and Monforte, Antonella d'Arminio, additional

Published
2012
Full Text
View/download PDF

33. Comparative Effectiveness of Initial Antiretroviral Therapy Regimens

Author

Mugavero, Michael J., primary, May, Margaret, additional, Ribaudo, Heather J., additional, Gulick, Roy M., additional, Riddler, Sharon A., additional, Haubrich, Richard, additional, Napravnik, Sonia, additional, Abgrall, Sophie, additional, Phillips, Andrew, additional, Harris, Ross, additional, Gill, M. John, additional, de Wolf, Frank, additional, Hogg, Robert, additional, Günthard, Huldrych F., additional, Chêne, Geneviève, additional, D'Arminio Monforte, Antonella, additional, Guest, Jodie L., additional, Smith, Colette, additional, Murillas, Javier, additional, Berenguer, Juan, additional, Wyen, Christoph, additional, Domingo, Pere, additional, Kitahata, Mari M., additional, Sterne, Jonathan A. C., additional, and Saag, Michael S., additional

Published
2011
Full Text
View/download PDF

34. Detrimental Effect of Atazanavir Plasma Concentrations on Total Serum Bilirubin Levels in the Presence of UGT1A1 Polymorphisms

Author

Cicconi, Paola, primary, Bini, Teresa, additional, Barassi, Alessandra, additional, Casana, Maddalena, additional, Turri, Olivia, additional, Pateri, Francesca, additional, Marchetti, Giulia C, additional, Biondi, Maria Luisa, additional, d'Eril, Gianlodovico Melzi, additional, and Manforte, Antonella d'Arminio, additional

Published
2011
Full Text
View/download PDF

35. Is There Any Potential for First-Line Etravirine Use? Analysis From a Large Data Set of Antiretroviral Therapy-Naive HIV-Infected Patients Undergoing Resistance Test

Author

Zaccarelli, Mauro, primary, Antinori, Andrea, additional, Cozzi-Lepri, Alessandro, additional, Mussini, Cristina, additional, Palamara, Guido, additional, Santoro, Maria Mercedes, additional, Spagnuolo, Vincenso, additional, Monforte, Antonella d'Arminio, additional, Perno, Carlo Federico, additional, and Ceccherini-Silberstein, Francesca, additional

Published
2010
Full Text
View/download PDF

36. Effect of Baseline CD4 Cell Counts on the Clinical Significance of Short-Term Immunologic Response to Antiretroviral Therapy in Individuals With Virologic Suppression

Author

Moore, David M, primary, Harris, Ross, additional, Lima, Viviane, additional, Hogg, Bob, additional, May, Margaret, additional, Yip, Benita, additional, Justice, Amy, additional, Mocroft, Amanda, additional, Reiss, Peter, additional, Lampe, Fiona, additional, Chêne, Geneviève, additional, Costagliola, Dominique, additional, Elzi, Luigia, additional, Mugavero, Michael J, additional, Monforte, Antonella D'Arminio, additional, Sabin, Caroline, additional, Podzamczer, Daniel, additional, Fätkenheuer, Gerd, additional, Staszewski, Schlomo, additional, Gill, John, additional, and Sterne, Jonathan A C, additional

Published
2009
Full Text
View/download PDF

37. CD8+ Hyperactivation and Senescence Correlate With Early Carotid Intima-Media Thickness in HIV+ Patients With No Cardiovascular Disease

Author

Tincati, Camilla, primary, BellistrÌ, Giusi M, additional, Casana, Maddalena, additional, Merlini, Esther, additional, Comi, Laura, additional, Bai, Francesca, additional, Sinigaglia, Elisabetta, additional, Cristina, Maurizio, additional, Carpani, Giovanni, additional, Bini, Teresa, additional, Monforte, Antonella d'Arminio, additional, and Marchetti, Giulia, additional

Published
2009
Full Text
View/download PDF

38. Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients

Author

Morsica, Giulia, primary, Bagaglio, Sabrina, additional, Cicconi, Paola, additional, Capobianchi, Maria R, additional, Pellizzer, Giampietro, additional, Caramello, Pietro, additional, Orani, Anna, additional, Moioli, Cristina, additional, Rizzardini, Giuliano, additional, Uberti-Foppa, Caterina, additional, Puoti, Massimo, additional, and Monforte, Antonella d'Arminio, additional

Published
2009
Full Text
View/download PDF

42. Determinants of Virologic and Immunologic Outcomes in Chronically HIV-Infected Subjects Undergoing Repeated Treatment Interruptions

Author

Palmisano, Lucia, primary, Giuliano, Marina, additional, Bucciardini, Raffaella, additional, Fragola, Vincenzo, additional, Andreotti, Mauro, additional, Galluzzo, Clementina M, additional, Pirillo, Maria F, additional, Weimer, Liliana E, additional, Arcieri, Romano, additional, Germinario, Elena A P, additional, Amici, Roberta, additional, Mancini, Maria Grazia, additional, Monforte, Antonella d'Arminio, additional, Castelli, Francesco, additional, Caramello, Pietro, additional, and Vella, Stefano, additional

Published
2007
Full Text
View/download PDF

45. Is Moderate HIV Viremia Associated With a Higher Risk of Clinical Progression in HIV-Infected People Treated With Highly Active Antiretroviral Therapy

Author

Murri, Rita, primary, Lepri, Alessandro Cozzi, additional, Cicconi, Paola, additional, Poggio, Antonio, additional, Arlotti, Massimo, additional, Tositti, Giulia, additional, Santoro, Domenico, additional, Soranzo, Maria Luisa, additional, Rizzardini, Giuliano, additional, Colangeli, Vincenzo, additional, Montroni, Maria, additional, and Monforte, Antonella D'Arminio, additional

Published
2006
Full Text
View/download PDF

48. Interruption of Highly Active Antiretroviral Therapy in HIV Clinical Practice

Author

Monforte, Antonella d'Arminio, primary, Cozzi-Lepri, Alessandro, additional, Phillips, Andrew, additional, De Luca, Andrea, additional, Murri, Rita, additional, Mussini, Cristina, additional, Grossi, Paolo, additional, Galli, Andrea, additional, Zauli, Tiziano, additional, Montroni, Maria, additional, Tundo, Paolo, additional, and Moroni, Mauro, additional

Published
2005
Full Text
View/download PDF

49. Delayed Presentation and Late Testing for HIV: Demographic and Behavioral Risk Factors in a Multicenter Study in Italy

Author

Girardi, Enrico, primary, Aloisi, Maria Stella, additional, Arici, Claudio, additional, Pezzotti, Patrizio, additional, Serraino, Diego, additional, Balzano, Roberta, additional, Vigevani, Gianmarco, additional, Alberici, Francesco, additional, Ursitti, Maria, additional, D???Alessandro, Margherita, additional, Monforte, Antonella d???Arminio, additional, and Ippolito, Giuseppe, additional

Published
2004
Full Text
View/download PDF

50. Prevalence of HIV-1 Primary Drug Resistance in Seroconverters of the ICoNA Cohort Over the Period 1996???2001

Author

Violin, Michela, primary, Velleca, Rossella, additional, Cozzi-Lepri, Alessandro, additional, Riva, Chiara, additional, Grossi, Paolo Antonio, additional, Carnevale, Giuseppe, additional, Rizzardini, Giuliano, additional, Petrelli, Enzo, additional, Perno, Carlo Federico, additional, Monforte, Antonella d??Arminio, additional, and Balotta, Claudia, additional

Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results